View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
June 10, 2019

Itamar Medical’s sleep apnoea test gets US regulatory clearance

Israeli diagnostics device manufacturer Itamar Medical has secured US Food and Drug Administration (FDA) 510(k) clearance for the disposable home sleep apnoea test (HSAT), WatchPAT One.

Israeli diagnostics device manufacturer Itamar Medical has secured US Food and Drug Administration (FDA) 510(k) clearance for the disposable home sleep apnoea test (HSAT), WatchPAT One.

Based on the company’s WatchPAT technology, the test is designed for use in clinics and practices with limited resources, infrastructure or capital.

WatchPAT One can be linked to the WatchPAT device via the company’s smartphone app. The test collects sleep study data, which is automatically transmitted to Itamar Medical’s CloudPAT server.

After the completion of the test, WatchPAT’s True Sleep Time, Sleep Architecture and Central Plus algorithms are used to automatically generate a comprehensive report and send to the prescribing physician.

Itamar Medical president and CEO Gilad Glick said: “We expect the availability of a disposable WatchPAT system will improve patient access by increasing the number of physicians able to offer our cutting-edge technology to their patients.

“Additionally, as a disposable HSAT, WatchPAT One may have particular utility in the inpatient setting, where transmission of infection through reusable medical devices is a significant concern.”

The company focuses on research, development, sales and marketing of non-invasive medical devices to diagnose respiratory sleep disorders.

Its portfolio includes Total Sleep Solution, designed to enable comprehensive sleep apnoea management in different clinical settings to optimise patient care and minimise healthcare costs.

In addition, Itamar Medical offers a WatchPAT home-use diagnostic device for sleep breathing disorders.

“WatchPAT One may have particular utility in the inpatient setting, where transmission of infection through reusable medical devices is a significant concern.”

This device, which can be worn like a wrist-watch, uses finger based physiology and technology to facilitate testing for obstructive sleep apnoea.

It operates on Peripheral Arterial Tone (PAT) signal, which measures the arterial volume changes at the fingertip. These changes indicate the sympathetic nervous system activation.

The company additionally provides the EndoPAT system for testing endothelial dysfunction and to assess cardiovascular diseases risk.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network